In our study, drug-sensitivity analysis revealed that the expression of NLRP7, NLRP2, NOD1, and CASP6 was positively correlated with some or most drugs in the cancer therapeutic response portal database (Fig. 7K). The gene discussed is NLRP7; the disease is cancer.